PhotoMedex to offer Photo Therapeutics product line in US
This article was originally published in Clinica
Executive Summary
Medical laser specialist PhotoMedex is set to make Photo Therapeutics’ Omnilux line of light-based therapy products available to US dermatologists. PhotoMedex will distribute the Omnilux Blue for the treatment of acne and actinic keratosis, the Omnilux Plus for wound healing and skin rejuvenation, and the Omnilux Revive, which can be used in combination with Omnilux blue for acne or in combination with Omnilux plus for wound healing. All the Omnilux devices incorporates a narrowband light-emitting diode (LED) technology. This distribution deal follows an acquisition agreement in the fourth quarter of 2008 between the two firms, in which PhotoMedex agreed to buy Photo Therapeutics for around $13m (see Clinica No 1319, p 13). Financial details were not revealed.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals